TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.6885
-0.0383 (-5.27%)
At close: Nov 20, 2026, 4:00 PM EST
0.6905
+0.0020 (0.29%)
After-hours: Nov 20, 2026, 4:10 PM EST
TELA Bio Revenue
TELA Bio had revenue of $18.96M in the quarter ending September 30, 2026, a decrease of -8.36%. This brings the company's total for the last twelve months to $78.18M, up 1.46% year-over-year. In the year 2025, TELA Bio had annual revenue of $80.28M with 15.84% growth. That makes TELA Bio the 24,653rd largest company in the world by revenue and 3,456th in the United States.
Revenue (ttm)
$78.18M
Revenue Growth
+1.46%
P/S Ratio
0.40
Revenue / Employee
$358,615
Employees
218
Market Cap
31.11M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 80.28M | 10.98M | 15.84% |
| Dec 31, 2024 | 69.30M | 10.85M | 18.56% |
| Dec 31, 2023 | 58.45M | 17.04M | 41.13% |
| Dec 31, 2022 | 41.42M | 11.96M | 40.58% |
| Dec 31, 2021 | 29.46M | 11.25M | 61.77% |
| Dec 31, 2020 | 18.21M | 2.77M | 17.91% |
| Dec 31, 2019 | 15.45M | 7.17M | 86.68% |
| Dec 31, 2018 | 8.27M | 4.03M | 94.91% |
| Dec 31, 2017 | 4.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nortech Systems | 127.22M |
| Xtant Medical Holdings | 100.56M |
| Myomo | 45.50M |
| electroCore | 37.97M |
| Rapid Micro Biosystems | 36.87M |
| QT Imaging Holdings | 29.58M |
| Sensus Healthcare | 16.62M |
| Spectral AI | 14.46M |
TELA News
- 11 days ago - Tela Bio files $150M mixed securities shelf - TheFly
- 11 days ago - TELA Bio Earnings Call Transcript: Q3 2026 - Transcripts
- 11 days ago - TELA Bio Earnings release: Q3 2026 - Filings
- 11 days ago - TELA Bio Quarterly report: Q3 2026 - Filings
- 11 days ago - Tela Bio reports Q3 EPS (16c), consensus (16c) - TheFly
- 11 days ago - TELA Bio Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 12 days ago - TELA Bio Registration statement: Registration filing - Filings
- 15 days ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire